Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function

Authors:

Abstract
Altered intestinal permeability has been correlated with Parkinson’s pathophysiology in the enteric nervous system, before manifestations in the central nervous system (CNS). The inflammatory endotoxin or lipopolysaccharide (LPS) released by gut bacteria is known to modulate α-synuclein amyloidogenesis through the formation of intermediate nucleating species. Here, biophysical techniques in conjunction with microscopic images revealed the molecular interaction between lipopolysaccharide and α-synuclein that induce rapid nucleation events. This hetero-molecular interaction stabilizes the α-helical intermediates in the α-synuclein aggregation pathway. Multitude NMR studies probed the residues involved in the LPS-binding structural motif that modulates the nucleating forms, affecting the cellular internalization and associated cytotoxicity. Collectively, our data characterizes this hetero-molecular interaction associated with an alternative pathway in Parkinson’s disease progression.
Funding Information
  • Council of Scientific and Industrial Research (02(0292)/17/EMR-II)
  • University Grants Commission

This publication has 55 references indexed in Scilit: